Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-25 @ 3:44 AM
NCT ID:
NCT02303002
Brief Summary:
This is a safety and efficacy study of botulinum toxin type A in subjects with glabellar frown lines.
Study:
NCT02303002
Study Brief:
Protocol Section:
NCT02303002